FDA reviewed many published research studies, including both nonclinical and clinical data. Nonclinical Studies We reviewed published nonclinical studies showing that early exposure to anesthetic drugs can produce adverse neurotoxic effects in different species, including simple nematodes, rats, and nonhuman primates.1-20 The studies demonstrate that the use of anesthetic drugs during the period of rapid…
FDA Drug Safety Communication: Updated FDA review concludes that use of type 2 diabetes medicine pioglitazone may be linked to an increased risk of bladder cancer
We systematically reviewed published epidemiological studies evaluating the risk of bladder cancer with pioglitazone use. Some studies found an increased risk of bladder cancer with pioglitazone use and others did not. The following studies are presented to illustrate the inconsistent findings among all reviewed studies. The manufacturer of pioglitazone, Takeda Pharmaceuticals, conducted a 10-year prospective…
Safety Testing of Drug Metabolites
%PDF-1.6% 136 0 objstream hWtJ{[ Y}aك7% E_,kS}E#aȑvA;TYKqnv3% Xcuѱmm?9 Dգc9ǔ
Nonprescription Sunscreen Drug Products – Safety and Effectiveness Data
%PDF-1.5% 730 0 objendobj 736 0 obj/Filter/FlateDecode/ID[]/Index[730 13]/Info 729 0 R/Length 53/Prev 137141/Root 731 0 R/Size 743/Type/XRef/W[1 2 1]stream hbbd“b`${@9H/~LL@#:?
Generic Drug User Fee Amendments of 2012: Questions and Answers Related to User Fee Assessments
%PDF-1.5% 1166 0 objendobj 1174 0 obj/Filter/FlateDecode/ID[]/Index[1166 19]/Info 1165 0 R/Length 57/Prev 199728/Root 1167 0 R/Size 1185/Type/XRef/W[1 2 1]stream hbbd“b`@`,Al $ާ001Ȃ10C
Non-Inferiority Clinical Trials
%PDF-1.5% 2219 0 objendobj 2225 0 obj/Filter/FlateDecode/ID[]/Index[2219 13]/Info 2218 0 R/Length 52/Prev 438421/Root 2220 0 R/Size 2232/Type/XRef/W[1 2 1]stream hbbd“b`$g’ n `9,FtO?
Advisory to Drug and Dietary Supplement Manufacturers, Compounding Pharmacies and Distributors of Excipients and Dietary Ingredients – FDA Detects High Levels of Peroxide in Crospovidone
<!– –> <!– Page Last Updated: 10/27/2016 –> Page Last Updated: 10/27/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players. Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français |…
Drug Trials Snapshots: EXONDYS 51
HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the clinical trials that supported the FDA approval of this drug, and whether there were differences among sex, race, and age groups. The “MORE INFO” bar shows more detailed, technical content for each section. The Snapshot is intended as one tool for…
La FDA advierte sobre el riesgo de reactivación de la hepatitis B en algunos pacientes tratados con antivirales de acción directa para la hepatitis C
La Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) de los Estados Unidos advierte sobre el riesgo de que el virus de la hepatitis B (VHB) vuelva a convertirse en una infección activa en pacientes que tienen o han tenido previamente una infección con este virus y son tratados con determinados medicamentos…